Related Experiment Video
Updated: Aug 9, 2025

09:41
Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
Published on: February 25, 2021
23.4K
Low-density lipoprotein: a versatile nanoscale platform for targeted delivery
Luyao Dai1,2, Shuaijun Li2, Qian Hao1,2
1Department of Oncology, The Second Affiliated Hospital, Medical School of Xi'an Jiaotong University Xi'an Shaanxi 710061 China.
Nanoscale Advances
|February 17, 2023
Summary
Low-density lipoprotein (LDL) shows promise as a nanocarrier for targeted delivery due to its unique properties. This review explores LDL
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Lipid Metabolism
Background:
- Low-density lipoprotein (LDL) is crucial for lipid metabolism.
- LDL possesses unique nanostructural properties: high payload capacity, long circulation time, biocompatibility, small size, and natural targeting.
- These characteristics make LDL particles attractive for drug delivery applications.
Purpose of the Study:
- To review the structure, composition, and properties of LDL particles as delivery systems.
- To summarize the current research status and progress of LDL in targeted diagnosis and therapy.
- To discuss the potential clinical applications of LDL as a drug delivery vehicle.
Main Methods:
- Literature review of studies on LDL structure and function.
- Analysis of research on LDL-based targeted delivery systems.
- Synthesis of information on LDL's advantages, limitations, and modifications.
Main Results:
- LDL exhibits superior payload capacity, prolonged circulation, biocompatibility, and natural targeting.
- LDL delivery systems have demonstrated potential in targeted diagnosis and therapy.
- Reconstruction of LDL particles can enhance their delivery capabilities.
Conclusions:
- LDL particles offer a promising platform for targeted drug delivery.
- Further research and development are needed to optimize LDL-based systems for clinical translation.
- LDL holds significant potential as an effective delivery vehicle in future therapeutics.

